School Reintegration After Childhood Cancer Treatment: A Mixed-Methods Study of Re-entry Patterns, Barriers, Facilitators, and Academic Challenges at a Regional Cancer Centre in South India

For many children, the journey through cancer ends not with a final medical test, but with a return to the classroom. While medical advances have turned what was once a fatal diagnosis into a manageable condition for many, the path back to a normal life involves more than just physical recovery. Once the intense treatments stop, survivors face a different kind of challenge: re-entering the school system they left behind. This transition is rarely seamless. Children often struggle with lingering fatigue, gaps in their learning, and the social anxiety of returning to peers who may not understand their experience. In wealthier nations, support systems often exist to help navigate this shift, but in many parts of the world, the focus remains almost entirely on survival, leaving the educational and social recovery of these young people largely unaddressed.

Researchers at a major medical center in southern India set out to understand exactly how this return to school plays out for families in their region. They wanted to know not just how many children managed to go back to class, but why some stayed home even when they were medically ready. The team conducted a detailed study involving 150 families whose children had finished the most intensive phase of cancer treatment. They combined a written survey with in-depth conversations with parents to build a complete picture of the barriers and helpers involved in this critical step. Their work reveals that while most children do return to school, the process is often delayed by fear, and a significant number of students face academic struggles that could shape their future.

The study began by screening children aged four to eighteen who had completed their primary cancer therapy. Out of 161 children checked, 150 were found to be healthy enough to return to school. The researchers asked the parents to fill out a structured questionnaire about their child's school status, attendance, and any difficulties they faced. Following this, the team spoke personally with fourteen parents, five of whom had children who had not yet returned to school and nine whose children had. These conversations allowed the researchers to hear the stories behind the numbers, exploring the specific worries and hopes that drive a family's decision to send a child back to class.

The results showed that the majority of children, 128 out of 150, did eventually rejoin school. On average, this happened about thirteen and a half months after the initial diagnosis and five months after finishing the intensive treatment. For most of these families, the decision to return was driven by the child's own desire to go back. However, the path was not always direct. Nearly 40 percent of the children who did return faced a delay of more than three months, even though their doctors said they were well enough to attend. The primary reason for these delays was not the child's health, but the parents' fears. Many caregivers worried that the school environment would expose their child to infections or that the child would struggle with the physical demands of the day.

Once back in the classroom, the children faced a different set of hurdles. Almost all of the returning students missed school days, either for scheduled hospital visits or because they were too tired or worried about getting sick. Despite these absences, the social environment was surprisingly supportive. Most parents reported that their children faced no bullying or discrimination from teachers or classmates. The real challenge, however, was academic. About one-quarter of the children who returned found it difficult to catch up with their studies. The data showed a clear link between the length of the cancer treatment and the severity of these academic struggles; children who underwent therapy for longer than two years were significantly more likely to fall behind.

The study also identified a group of children who, despite being medically cleared, had not returned to school at all. This group included 22 children, representing 15 percent of the total. For these families, the barriers were more profound. The most common reason cited was a deep-seated fear of treatment side effects, followed by concerns about the child's ability to handle the academic workload. Interestingly, the researchers found that boys were more likely to be in this non-returning group than girls, and children who had longer treatment courses were also at higher risk of not going back. While the study suggests these patterns, the authors note that more research is needed to confirm if these are true trends or specific to their local group.

The conversations with parents added a human layer to these statistics, revealing a complex mix of love, fear, and hope. Many parents expressed a strong desire for their children to regain a sense of normalcy and independence, viewing school as the first step toward that goal. Yet, this hope was often held back by a lack of trust in the school system's ability to support a child with a cancer history. Some parents recounted stories of schools refusing to admit their children, forcing them to search for alternative options or keep their children at home. The researchers found that while many of these children were enrolled in private tutoring, this could not replace the social and emotional benefits of a real school environment.

The authors conclude that the current approach in their region, which focuses heavily on medical survival, needs to expand to include early planning for education. They suggest that doctors should begin talking about school reintegration as soon as a child is diagnosed, rather than waiting until treatment is over. Simple steps, such as maintaining contact with teachers during treatment or providing virtual learning support, could help bridge the gap. The study highlights that while the medical battle may be won, the journey to a full recovery requires a coordinated effort between families, schools, and healthcare providers to ensure that every child survivor has the chance to return to the classroom and thrive.